Each year, trainees and recent doctoral graduates are encouraged to apply for WORLDSymposium’s Young Investigator Award that provides a partial scholarship to attend WORLDSymposium™. New this year: To increase opportunities for basic scientists to present their research, WORLDSymposium™ is offering ten (10) Young Investigator Awards specifically for Basic Science Abstracts. Graduate students and those who are within the first 3 years after completing a graduate degree are eligible. Those who submit an abstract as the first-author will be considered eligible for the award, and will be selected by the Program Committee on the basis of the content of the abstract. Abstract Submissions for the 14th Annual WORLDSymposium™ opened on July 1, 2017. The Program Committee will select awardees from the first authors of abstracts submitted by the October 1, 2017 deadline. All eligible applicants will be notified by November 15, 2017 of the status of their application for the award. The Young Investigator and New Treatment Award presentations will occur at 5:15 p.m. on Monday, February 5, 2018. This will be followed by a WORLDSymposium™ opening reception in the exhibit hall at 5:30 p.m.
WORLDSymposium™ 2018 is Accepting Nominations!
Nominations for the newly-renamed Roscoe O. Brady Award opened on July 14, 2017. The Award is presented annually to recognize substantial contributions to lysosomal disease research and therapy. The Award will be presented at WORLDSymposium™ 2018 at the opening session on Tuesday, February 6, 2018 at 7:45 a.m. The 14th Annual WORLDSymposium™ convenes February 5–9, 2018 at Manchester Grand Hyatt San Diego hotel in San Diego, California. The nominations deadline was August 15, 2017.
Nominations are also being accepted for the Patient Advocate Leader (PAL) Award, which will be presented at WORLDSymposium™ on Wednesday morning, February 7, 2018, prior to the Keynote Speaker. This Award recognizes individuals contributing directly to lives of patients and families dealing with a lysosomal disease through disease awareness and education, community mobilization, non-profit development and/or good governance activities, patient care, and support programs. The nominations deadline was also August 15, 2017.